SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328700. A total of 42 filers reported holding SUNESIS PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $65,000 | -78.9% | 192,778 | -55.0% | 0.00% | – |
| Q3 2019 | $308,000 | +6.2% | 428,257 | +301.7% | 0.00% | – |
| Q1 2018 | $290,000 | +408.8% | 106,599 | +594.4% | 0.00% | – |
| Q4 2017 | $57,000 | +119.2% | 15,351 | +14.6% | 0.00% | – |
| Q3 2017 | $26,000 | -27.8% | 13,390 | 0.0% | 0.00% | – |
| Q2 2017 | $36,000 | -35.7% | 13,390 | -2.1% | 0.00% | – |
| Q1 2017 | $56,000 | – | 13,673 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 1,133,583 | $4,104,000 | 3.61% |
| GREAT POINT PARTNERS LLC | 1,537,873 | $5,567,000 | 1.14% |
| BVF INC/IL | 1,392,720 | $5,042,000 | 1.01% |
| Boxer Capital, LLC | 525,000 | $1,901,000 | 0.74% |
| Vivo Capital, LLC | 500,000 | $1,810,000 | 0.60% |
| Healthcare Value Capital, LLC | 150,000 | $543,000 | 0.58% |
| Cormorant Asset Management, LP | 1,000,000 | $3,620,000 | 0.49% |
| Telemetry Investments, L.L.C. | 120,807 | $437,000 | 0.25% |
| Palo Alto Investors LP | 1,162,473 | $4,208,000 | 0.24% |
| NEA Management Company, LLC | 1,298,274 | $4,700,000 | 0.19% |